Annual report [Section 13 and 15(d), not S-K Item 405]

Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities

v3.26.1
Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities
12 Months Ended
Dec. 31, 2025
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities

Note 4 – Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities

 

Cash, Cash Equivalents and Restricted Cash

 

The Company presents restricted cash with cash and cash equivalents in the Consolidated Statements of Cash Flows. Restricted cash at December 31, 2025 and 2024 of $250 represents funds the Company is required to set aside as collateral, primarily for one of the Company’s operating leases and other purposes.

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the Consolidated Balance Sheets to the total of the amounts in the Consolidated Statements of Cash Flows as of December 31, 2025, December 31, 2024 and December 31, 2023:

 

   

December 31,

2025

   

December 31,

2024

   

December 31,

2023

 
Cash and cash equivalents   $ 3,999     $ 7,284     $ 4,787  
Restricted cash included in current/non-current assets     250       250       250  
Cash, cash equivalents and restricted cash in the statement of cash flows   $ 4,249     $ 7,534     $ 5,037  

 

Marketable Debt Securities

 

The Company classified its investments in marketable debt securities as available-for-sale and as a current asset. The Company’s investments in marketable debt securities were carried at fair value, with unrealized gains and losses included as a separate component of stockholders’ equity. Unrealized losses and gains were classified as other comprehensive (loss)/income and costs are determined on a specific identification basis. Realized gains and losses from marketable debt securities are recorded in other income, net. The Company did not incur any realized gains and losses during the years ended December 31, 2025 and 2024. For the years ended December 31, 2025 and 2024, the Company recorded unrealized gains of $0 and $221, respectively.

 

The Company did not own any marketable debt securities at December 31, 2025 and 2024.